结构引导的功能抑制与AML相关的DNMT3A热点突变
Jiuwei Lu1, Yiran Guo2,3, Jiekai Yin4
1Department of Biochemistry, University of California, Riverside, CA, USA.
Nature communications
|April 10, 2024
概括
在DNA甲基转移酶DNMT3A (R882) 中的热点突变导致急性髓性白血病 (AML) 的异常DNA甲基化. 将DNMT3A转换为DNMT3B可以抑制聚合,恢复正常的DNA甲基化,并提供潜在的癌症治疗策略.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症研究 癌症研究
背景情况:
- 通过DNA甲基转移酶 (DNMTs) 调节的DNA甲基化对于发育至关重要.
- 在DNMT3A中发生的突变,特别是Arg882 (R882) 中发生的突变,与急性髓性白血病 (AML) 的发病有关.
- 在DNMT3A R882突变引起的功能障碍背后的分子机制尚未完全理解.
研究的目的:
- 阐明DNMT3A R882突变的结构和机制基础.
- 研究这些突变如何影响DNMT3A寡合化和DNA甲基化.
- 探索针对AML中的DNMT3A功能障碍的治疗策略.
主要方法:
- DNMT3A甲基转移酶域的X射线晶体学.
- 生物化学测试以评估聚合和酶活性.
- 细胞和基因组DNA甲基化分析.
主要成果:
- 晶体结构显示DNMT3A的寡合化与DNMT3B不同,R882突变增强了分子间接触.
- 在DNMT3A中发生的DNMT3B类突变抑制了R882诱导的聚合,并增加了基质接入.
- 这些变化消除了R882突变的主导负效应,纠正AML细胞中异常的DNA低甲基化.
结论:
- 在AML中,DNMT3A R882突变通过与DNMT3B不同的机制促进异常的寡合化和DNA低甲基化.
- 通过模仿DNMT3B功能来调节DNMT3A寡合化,可以逆转致病效应.
- 这项研究为AML治疗提供了机制性见解和潜在的治疗途径.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K


